Suppr超能文献

在存在不依从性的整群随机试验中,基于比值比进行非劣效性检验和样本量确定。

Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.

作者信息

Lui Kung-Jong, Chang Kuang-Chao

机构信息

Mathematics and Statistics, San Diego State University, San Diego, CA 92182-7720, USA.

出版信息

J Biopharm Stat. 2011 Jan;21(1):94-110. doi: 10.1080/10543401003602623.

Abstract

Because the odds ratio (OR) possesses certain desirable statistical properties, the OR has been recommended elsewhere to measure the relative treatment effect in establishing non-inferiority. For cost efficiency, we may often employ a cluster randomized trial (CRT), in which randomized units are clusters of patients. Furthermore, it is not uncommon to encounter data in which there are patients not complying with their assigned treatment. Under the Dirichlet multinomial model, we have developed a test statistic for assessing non-inferiority based on the OR between two treatments under a CRT with noncompliance. We have further derived a sample size formula accounting for both noncompliance and the intraclass correlation for a desired power 1 - β of detecting non-inferiority with respect to the OR at a nominal α level. Using Monte Carlo simulation, we have evaluated the performance of the proposed test statistic and sample size formula. Finally, we use the CRT studying the effect of vitamin A supplementation on mortality among preschool children to illustrate the use of the sample size formula given here.

摘要

由于比值比(OR)具有某些理想的统计特性,在其他地方有人建议使用OR来衡量在确立非劣效性时的相对治疗效果。出于成本效益的考虑,我们可能经常采用整群随机试验(CRT),其中随机分组的单位是患者群。此外,遇到患者不遵守分配治疗方案的数据并不罕见。在狄利克雷多项分布模型下,我们开发了一种检验统计量,用于在存在不依从性的CRT中基于两种治疗之间的OR评估非劣效性。我们进一步推导了一个样本量公式,该公式考虑了不依从性和组内相关性,以在名义α水平下以期望的检验效能1 - β检测相对于OR的非劣效性。通过蒙特卡罗模拟,我们评估了所提出的检验统计量和样本量公式的性能。最后,我们使用研究维生素A补充剂对学龄前儿童死亡率影响的CRT来说明此处给出的样本量公式的用法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验